<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362975">
  <stage>Registered</stage>
  <submitdate>3/09/2012</submitdate>
  <approvaldate>11/09/2012</approvaldate>
  <actrnumber>ACTRN12612000977875</actrnumber>
  <trial_identification>
    <studytitle>A study to determine patient specific and general beliefs towards medication and their treatment compliance to selected systemic therapies in chronic inflammatory diseases (ALIGN)</studytitle>
    <scientifictitle>Multi-country, cross sectional study to determine patient specific and General beliefs towards medication and their treatment compliance to selected systemic therapies in chronic inflammatory diseases (IMID)</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym>ALIGN</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Rheumatoid Arthritis</healthcondition>
    <healthcondition>Psoriasis</healthcondition>
    <healthcondition>Psoriatic Arthritis</healthcondition>
    <healthcondition>Ankylosing spondylitis</healthcondition>
    <healthcondition>Crohn's disease</healthcondition>
    <healthcondition>Ulcerative Colitis</healthcondition>
    <healthcondition>Inflammatory bowel disease.</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Rheumatoid arthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Inflammatory bowel disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Non-interventional Questionnaire study. Looking at understanding better patient's attitudes, beliefs and risk concerns towards their systemic medication.
Duration of the study is a single visit to complete 4 questionnaires. The questionnaires will take 30-45 minutes to complete.</interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To describe patients' beliefs and risk concerns in patients with chronic inflammatory disaese toward their systemic medication via completion of validated questionnaires on one visit.
Questionnaires to be used in the study: Brief Illness Perception Questionnaire, Patient Health Questionnaire, Beliefs Medication questionnaire, Visual Analog Scale, and Morisky Medication Adherence Scale.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To correlate patients' beliefs and risk concerns with disease characteristics via completion of validated questionnaires.
Questionnaires to be used in the study: Brief Illness Perception Questionnaire, Patient Health Questionnaire, Beliefs Medication questionnaire, Visual Analog Scale, and Morisky Medication Adherence Scale.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To assess and describe beliefs about TNFinhibitor treatment as well as systemic treatments other than biologics via completion of validated questionnaires.
Questionnaires to be used in the study: Brief Illness Perception Questionnaire, Patient Health Questionnaire, Beliefs Medication questionnaire, Visual Analog Scale, and Morisky Medication Adherence Scale.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To describe self reported compliance levels with TNFinhibitors and DMARDs, NSAIDs and IMM in patients with IMID as assessed by MMAS-4 and VAS for all treatments in each patient on one visit.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To assess the correlation of patients beliefs about treatments with the respective treatment compliance levels and patient perception parameters like illness beliefs and depressive symptoms. using Brief illness Perception Questionnaire and Patient health Questionnaire on one visit.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To describe patients beliefs about medicine in relation to treatment duration via completion of validated questionnaires on one visit.
Questionnaires to be used in the study: Brief Illness Perception Questionnaire, Patient Health Questionnaire, Beliefs Medication questionnaire, Visual Analog Scale, and Morisky Medication Adherence Scale.</outcome>
      <timepoint>Each patient on one visit</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Female/male
18 years or over
Patients with Immune Mediated Inflammatory Disorders as diagnosed by a rheumatologist, gastroenterologist or dermatologist.
On current treatment with systemic either conventional and/or biologic immuno-modulating and/or disease-modifying drugs.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not applicable</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Psychosocial</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>11/09/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>330</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2050</postcode>
    <postcode>2298</postcode>
    <postcode>4102</postcode>
    <postcode>3128</postcode>
    <postcode>6005</postcode>
    <postcode>5000</postcode>
    <postcode>3079</postcode>
    <postcode>4000</postcode>
    <postcode>2217</postcode>
    <postcode>3084</postcode>
    <postcode>5042</postcode>
    <postcode>4560</postcode>
    <postcode>2500</postcode>
    <postcode>3144</postcode>
    <postcode>2170</postcode>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Wellington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Waikato</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>AbbVie Pty Ltd</primarysponsorname>
    <primarysponsoraddress>32-34 Lord St
Botany NSW 2019</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>AbbVie Pty Ltd</fundingname>
      <fundingaddress>32-34 Lord St
Botany NSW 2019</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of the ALIGN study is to better understand patients attitudes, beliefs and risks concerns towards their systemic medication.The ALIGN study deals with the collection of information only and is not designed for drug testing.
You will also be asked to complete four types of questionnaires and one visual analog scale which will take approximately 30 to 45 minutes. You will have the opportunity to seal your answered questionnaires in an envelope so that they are not disclosed to your treating doctor.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bellberry Ethics Committee</ethicname>
      <ethicaddress>229 Greenhill Rd
Dulwich SA 5065</ethicaddress>
      <ethicapprovaldate>15/08/2012</ethicapprovaldate>
      <hrec>2012-07-947</hrec>
      <ethicsubmitdate>8/08/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrew Weekes</name>
      <address>32-34 Lord St
Botany NSW 2019</address>
      <phone>+61 2 93849900</phone>
      <fax />
      <email>andrew.weekes@abbott.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Andrew Weekes</name>
      <address>32-34 Lord St
Botany NSW 2019</address>
      <phone>+61 2 93849900</phone>
      <fax />
      <email>andrew.weekes@abbott.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Vesna Roff</name>
      <address>32-34 Lord St
Botany NSW 2019</address>
      <phone>02 93849739</phone>
      <fax />
      <email>vesna.roff@abbott.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>